Kymera Therapeutics
Price & Volume
Stats
See moreOpen | $43.83 |
Previous Close | $43.70 |
Day Range | $43.18-$43.83 |
52W Range | $29.24-$53.27 |
Market Cap | $2.8B |
Shares Short | 8M |
Financials
See moreRevenue (12 Mos) | $87.5M |
Revenue Growth (YoY) | -20.9% |
Gross Profit (12 Mos) | -$133.8M |
Diluted EPS | -$2.34 |
News
See moreYahoo Finance • 4 months ago
Kymera Therapeutics Presents Preclinical Data for KT-621, a Potent, Selective, First-In-Class, Oral STAT6 Degrader at the EADV Congress
Yahoo Finance • 5 months ago
Kymera Therapeutics to Participate in Upcoming September Investor Conferences
Yahoo Finance • 11 months ago
Kymera Therapeutics, Inc. (NASDAQ:KYMR) Q4 2023 Earnings Call Transcript
Yahoo Finance • 11 months ago
Chief Medical Officer Jared Gollob Sells 46,137 Shares of Kymera Therapeutics Inc
About
CEO | Dr. Nello Mainolfi M.D., Ph.D. |
Address | 200 Arsenal Yards Boulevard, Watertown, MA, United States, 02472 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 184 |
